Skip to main content
. 2020 Apr 18;12(4):999. doi: 10.3390/cancers12040999
ATX autotaxin
BLM bleomycin
COX-2 cyclooxygenase-2
DEX dexamethasone
CCL C-C motif chemokine ligand
CXCL C-X-C motif chemokine ligand
G-CSF granulocyte-colony stimulating factor
GCLC glutamate-cysteine ligase catalytic subunit
IL interleukin
LPA lysophosphatidic acid, which at physiological pH is in a salt form, lysophosphatidate
LPAR1,2 LPA receptors types 1− and 2
LPP lipid phosphate phosphatase
Nrf2 nuclear erythroid 2-like 2
RT radiation therapy
TGF-β transforming growth factor β
TNFα tumor necrosis factor-α
VEGF vascular endothelial growth factor